TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

MAP Pharmaceuticals Inc. (NASDAQ:MAPP) Investor Alert: Investigation of Takeover Attempt by Allergan, Inc

  • If you purchased shares of MAP Pharmaceuticals Inc. (NASDAQ:MAPP) prior to January 22, 2013, and currently hold any of those NASDAQ:MAPP shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Jan. 23, 2013 (Shareholders Foundation) -- An investigation on behalf of investors in MAP Pharmaceuticals Inc. (NASDAQ:MAPP) shares was announced concerning whether the offer by Allergan, Inc to acquire MAP Pharmaceuticals Inc. for $25.00 per NASDAQ:MAPP share and the takeover process are unfair to investors in NASDAQ:MAPP shares. The investigation by a law firm concerns whether cert...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: